Llwytho...
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
The prevalence of type 2 diabetes (T2D) is increasing worldwide. Patients with T2D suffer from various diabetes-related complications. Since there are many patients with T2D that cannot be controlled by previously developed drugs, it has been necessary to develop new drugs, one of which is a glucago...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ann Pediatr Endocrinol Metab |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
The Korean Society of Pediatric Endocrinology
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5401818/ https://ncbi.nlm.nih.gov/pubmed/28443255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6065/apem.2017.22.1.15 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|